Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
As of close of business last night, Protalix BioTherapeutics Inc’s stock clocked out at $3.00, down -2.28% from its previous closing price of $3.07. In other words, the price has decreased by -$2.28 from its previous closing price. On the day, 0.54 million shares were traded. PLX stock price reached its highest trading level at $3.1 during the session, while it also had its lowest trading level at $2.97.
Ratios:
To gain a deeper understanding of PLX’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 6.82 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 32.16. For the most recent quarter (mrq), Quick Ratio is recorded 1.52 and its Current Ratio is at 2.34. In the meantime, Its Debt-to-Equity ratio is 0.13 whereas as Long-Term Debt/Eq ratio is at 0.09.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on June 08, 2020, Reiterated its Buy rating but revised its target price to $11 from $3 previously.
On April 17, 2017, Rodman & Renshaw reiterated its Buy rating and also lowered its target price recommendation from $4 to $5.
On April 04, 2016, Rodman & Renshaw started tracking the stock assigning a Buy rating and target price of $3.50.Rodman & Renshaw initiated its Buy rating on April 04, 2016, with a $3.50 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PLX now has a Market Capitalization of 234097792 and an Enterprise Value of 204793760. As of this moment, Protalix’s Price-to-Earnings (P/E) ratio for their current fiscal year is 114.07, and their Forward P/E ratio for the next fiscal year is 3.57. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.45 while its Price-to-Book (P/B) ratio in mrq is 5.27. Its current Enterprise Value per Revenue stands at 3.835 whereas that against EBITDA is 39.225.
Stock Price History:
The Beta on a monthly basis for PLX is -0.05, which has changed by 1.6315789 over the last 52 weeks, in comparison to a change of 0.092895746 over the same period for the S&P500. Over the past 52 weeks, PLX has reached a high of $3.10, while it has fallen to a 52-week low of $0.82. The 50-Day Moving Average of the stock is 20.16%, while the 200-Day Moving Average is calculated to be 72.38%.
Shares Statistics:
It appears that PLX traded 725.47K shares on average per day over the past three months and 846970 shares per day over the past ten days. A total of 75.85M shares are outstanding, with a floating share count of 72.17M. Insiders hold about 7.51% of the company’s shares, while institutions hold 6.71% stake in the company. Shares short for PLX as of 1744675200 were 740272 with a Short Ratio of 1.02, compared to 1741910400 on 650638. Therefore, it implies a Short% of Shares Outstanding of 740272 and a Short% of Float of 0.9900000000000001.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
